SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-009526
Filing Date
2024-06-27
Accepted
2024-06-27 08:52:23
Documents
19
Period of Report
2024-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20240626x8k.htm   iXBRL 8-K 49345
2 EX-2.1 chrs-20240626xex2d1.htm EX-2.1 445071
3 EX-99.1 chrs-20240626xex99d1.htm EX-99.1 10990
4 EX-99.2 chrs-20240626xex99d2.htm EX-99.2 563513
5 GRAPHIC chrs-20240626xex99d1001.jpg GRAPHIC 5167
  Complete submission text file 0001558370-24-009526.txt   1341423

Data Files

Seq Description Document Type Size
6 EX-101.SCH chrs-20240626.xsd EX-101.SCH 4530
7 EX-101.DEF chrs-20240626_def.xml EX-101.DEF 3160
8 EX-101.LAB chrs-20240626_lab.xml EX-101.LAB 12266
9 EX-101.PRE chrs-20240626_pre.xml EX-101.PRE 11153
22 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20240626x8k_htm.xml XML 4903
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 241075579
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)